Lung ultrasound for surfactant decision in premature babies
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born at 27 weeks plus 0 days to 34 weeks plus 6 days of pregnancy
- Breathing on your own but needing a breathing machine or help like a mask or nasal tubes
- Has a lung problem called Respiratory Distress Syndrome, seen on chest X-ray, or is at risk of getting it
- Born at this hospital (not transferred from another hospital)
- Not put on a breathing tube in the delivery room or within the first 2 hours of life
- No major birth defects or severe health problems like hydrops, inherited metabolism issues, or air leaking from lungs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving surfactant medication guided by a lung ultrasound, instead of by X-ray, helps preterm babies with breathing problems get better without needing a breathing tube. Babies in the study receive surfactant through a thin tube while still on non-invasive breathing support.
This trial uses bedside ultrasound to see how well the lungs and blood flow are working in premature babies who receive surfactant, a medicine that helps their lungs open up.
This study compares two ways of giving surfactant (a lung-coating medicine) to newborns with breathing trouble: LISA (a gentler, less invasive method) versus traditional breathing tube delivery. Researchers will use ultrasound to see how the medicine spreads in each baby's lungs to find the best approach.
This study uses lung ultrasound to see how different ways of giving surfactant (a medicine for breathing problems) affect preterm babies born before 32 weeks. It may help doctors choose the best method for your baby.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
Hear when a new Respiratory Distress Syndrome, Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.